244 related articles for article (PubMed ID: 8390533)
41. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
42. EBV/C3d receptor (CR2) interacts by its intracytoplasmic carboxy-terminal domain and two distinct binding sites with the p53 anti-oncoprotein and the p68 calcium-binding protein.
Frade R; Gauffre A; Hermann J; Barel M
J Immunol; 1992 Nov; 149(10):3232-8. PubMed ID: 1431101
[TBL] [Abstract][Full Text] [Related]
43. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction].
Oikawa O
Hokkaido Igaku Zasshi; 1995 Sep; 70(5):729-42. PubMed ID: 8543279
[TBL] [Abstract][Full Text] [Related]
44. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of a novel B cell activation gene.
Hong JX; Wilson GL; Fox CH; Kehrl JH
J Immunol; 1993 May; 150(9):3895-904. PubMed ID: 8473738
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion.
Knox PG; Young LS
Virology; 1995 Oct; 213(1):147-57. PubMed ID: 7483258
[TBL] [Abstract][Full Text] [Related]
48. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
49. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
[TBL] [Abstract][Full Text] [Related]
50. Infection of human thymocytes by Epstein-Barr virus.
Watry D; Hedrick JA; Siervo S; Rhodes G; Lamberti JJ; Lambris JD; Tsoukas CD
J Exp Med; 1991 Apr; 173(4):971-80. PubMed ID: 1706754
[TBL] [Abstract][Full Text] [Related]
51. Infection of human B lymphoma cells by Mycoplasma fermentans induces interaction of its elongation factor with the intracytoplasmic domain of Epstein-Barr virus receptor (gp140, EBV/C3dR, CR2, CD21).
Balbo M; Barel M; Lottin-Divoux S; Jean D; Frade R
FEMS Microbiol Lett; 2005 Aug; 249(2):359-66. PubMed ID: 16054780
[TBL] [Abstract][Full Text] [Related]
52. C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.
Kuraya M; Sato T; Fujita T
Microbiol Immunol; 1995; 39(2):145-51. PubMed ID: 7783687
[TBL] [Abstract][Full Text] [Related]
53. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
[TBL] [Abstract][Full Text] [Related]
54. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
Carel JC; Myones BL; Frazier B; Holers VM
J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.
Sauvageau G; Stocco R; Kasparian S; Menezes J
J Gen Virol; 1990 Feb; 71 ( Pt 2)():379-86. PubMed ID: 2155291
[TBL] [Abstract][Full Text] [Related]
56. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.
Levine J; Pflugfelder SC; Yen M; Crouse CA; Atherton SS
Reg Immunol; 1990-1991; 3(4):164-70. PubMed ID: 1966579
[TBL] [Abstract][Full Text] [Related]
57. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.
Rhodes GH; Valbracht JR; Nguyen MD; Vaughan JH
J Autoimmun; 1997 Oct; 10(5):447-54. PubMed ID: 9376072
[TBL] [Abstract][Full Text] [Related]
58. Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: viral RNA transcripts (Epstein-Barr-encoded small RNAs) are present in intratumoral lymphocytes but absent from the neoplastic cells.
Fend F; Hittmair A; Rogatsch H; Gredler E; Obrist P; Mikuz G
Mod Pathol; 1995 Aug; 8(6):622-5. PubMed ID: 8532694
[TBL] [Abstract][Full Text] [Related]
59. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
